Akanksha Schwarz doesn’t know which shot she got. She’s part of a clinical trial testing Novavax’s experimental Covid-19 vaccine, a blinded study that injected participants with either the real thing or a placebo. As an incentive, Novavax plans to vaccinate the placebo group sometime this spring, via a “crossover trial” that ensures that all study participants ultimately get the inoculation. …
Aurobindo Pharma on Thursday said it had entered into an agreement to develop, commercialise and manufacture U.S. firm COVAXX’s COVID-19 vaccine candidate for India and the United Nations Children's Fund agency. Managing Director N.Govindarajan said “we are proud to partner with COVAXX in developing the first-ever synthetic peptide-based vaccine to combat the COVID-19 pandemic. This vaccine has immense potential in …
